Innate Pharma S.A. (FRA:IDDA)
Germany · Delayed Price · Currency is EUR 1.490
-0.010 (-0.67%)
Jan 16, 2026, 4:00 PM EST
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of €145.05 million as of January 30, 2026. Its market cap has decreased by -0.77% in one year.
Market Cap
145.05M
Enterprise Value
112.05M
Revenue
12.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.49
Market Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 145.05M, an increase of 18,211.46%. That is a compound annual growth rate of 31.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 145.05M | -1.78% |
| Dec 31, 2025 | 147.67M | -7.67% |
| Dec 31, 2024 | 159.94M | -24.29% |
| Dec 29, 2023 | 211.24M | -19.93% |
| Dec 30, 2022 | 263.84M | -24.98% |
| Dec 31, 2021 | 351.67M | 28.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eleving Group | 186.27M |
| ADM Hamburg Aktiengesellschaft | 173.72M |
| Deutsche Real Estate AG | 172.89M |
| 029 Group SE | 156.00M |
| Greenland Resources | 151.41M |
| LEWAG Holding Aktiengesellschaft | 134.01M |
| Mineralbrunnen Überkingen-Teinach GmbH & Co. KGaA | 129.61M |
| Sparta AG | 125.60M |